Hexagon Nutrition Ltd.
HEXAGONMainboard
Ask IPO
Overview
Hexagon Nutrition Limited is a research-driven nutrition company focused on micronutrient premixes, clinical nutrition, wellness nutrition and therapeutic foods. Hexagon Nutrition Limited serves consumer, institutional and public health markets through brands such as Pentasure, Obesigo, PediaGold and Nutrone, while also supplying customised vitamin and mineral premixes to FMCG companies and micronutrient powders and ready-to-use foods for nutrition programs. Hexagon Nutrition Limited operates manufacturing facilities in Nashik, Chennai, Thoothukudi and Uzbekistan, has in-house R&D capabilities, and exports to more than 75 countries.
Opening Date
Jun 05, 2026
Closing Date
Jun 09, 2026
Listing Date
Jun 12, 2026
IPO Type
Mainboard
IPO Status
Upcoming
Issue Size
—
Fresh Issue
0 Cr
Offer for Sale
138.87 Cr
Price Band
₹42 - ₹45
Lot Size
333
IPO Timeline
Financials
Revenue
Profit After Tax (PAT)
IPO Objective
The main objectives of the issue are...
- •
To achieve the benefits of listing the equity shares on the stock exchanges, including enhanced visibility, broader investor participation, improved liquidity for shareholders and creation of a public market for the company’s equity shares.
- •
To carry out an offer for sale that provides partial liquidity and monetization opportunity to the identified selling shareholders through transfer of their existing equity shares to public investors.
- •
To strengthen the company’s public market profile and corporate brand, which may support future growth, stakeholder confidence and wider recognition across customers, partners and institutional participants.
- •
To complete the public issue process in compliance with applicable SEBI and stock exchange requirements, while enabling discovery of a market-driven price for the offered equity shares through the book building mechanism.
Key Performance Indicator
P/E Ratio
22.69
EPS
1.98
ROE
13.02%
ROCE
14.82%
RONW
12.12%
Debt to Equity Ratio
—
PAT Margin
9.81%
EBITDA Margin
14.03%
P/B
2.48
SWOT Analysis
Strengths
- •
Hexagon Nutrition Limited offers an integrated nutrition platform spanning premixes, branded clinical nutrition and therapeutic products across B2B, B2C and ESG segments.
- •
The company holds a strong position in customised micronutrient premixes in India and supplies global nutrition programs through micronutrient powders and ready-to-use foods.
- •
Manufacturing facilities in India and Uzbekistan, supported by certifications such as FSSC 22000, GMP and ISO standards, strengthen product quality and export capability.
- •
A broad distribution network across India, direct engagement with healthcare professionals and exports to more than 75 countries support market reach and diversification.
Weaknesses
- •
A large share of revenue comes from exports, exposing the business to global demand volatility, cross-border compliance requirements and foreign exchange movements.
- •
The offer is entirely an offer for sale, so the company will not receive fresh capital from the IPO to fund expansion or deleveraging.
- •
Capacity utilization across several manufacturing lines remains moderate, indicating under-absorption risk and dependence on stronger scale-up to improve efficiency.
- •
Customer and supplier concentration remains meaningful, with top customers and top suppliers contributing a significant portion of revenue and purchases.
Opportunities
- •
Rising health awareness, preventive healthcare adoption and increasing demand for clinical and wellness nutrition in India can support growth of branded products.
- •
Government and multilateral nutrition programs focused on fortification, malnutrition reduction and public health create demand for premixes, MNPs and therapeutic foods.
- •
Expansion into new therapy areas, personalized nutrition formats and adjacent categories such as functional foods and specialized supplements can diversify revenue.
- •
Growth in Tier II and Tier III markets, e-commerce channels and international geographies can deepen domestic penetration and broaden export reach.
Threats
- •
Stringent food, health, export and foreign investment regulations across multiple jurisdictions could delay approvals, increase compliance costs or restrict operations.
- •
Volatility in prices and availability of imported vitamins, minerals, whey proteins and other inputs can pressure margins and disrupt supply planning.
- •
Competition from large domestic and multinational nutrition, healthcare and FMCG players may intensify pricing pressure and brand spend requirements.
- •
Any quality failure, adverse regulatory finding or disruption in public health procurement programs could affect reputation, institutional business and financial performance.
Subscription Rate
Frequently Asked Questions about Hexagon Nutrition Ltd.
Hexagon Nutrition Limited is a research-driven nutrition company focused on micronutrient premixes, clinical nutrition, wellness nutrition and therapeutic foods. Hexagon Nutrition Limited serves consumer, institutional and public health markets through brands such as Pentasure, Obesigo, PediaGold and Nutrone, while also supplying customised vitamin and mineral premixes to FMCG companies and micronutrient powders and ready-to-use foods for nutrition programs. Hexagon Nutrition Limited operates manufacturing facilities in Nashik, Chennai, Thoothukudi and Uzbekistan, has in-house R&D capabilities, and exports to more than 75 countries.
The Hexagon Nutrition Ltd. IPO is scheduled to open for subscription on Jun 05, 2026 and close on Jun 09, 2026. Investors can apply for shares during this period through eligible platforms.
The price band for the Hexagon Nutrition Ltd. IPO is ₹42 to ₹45. Investors can place bids within this range once the issue opens.
The minimum lot size for the Hexagon Nutrition Ltd. IPO is 333 shares. The minimum investment amount ₹14,985.
The total issue size of the Hexagon Nutrition Ltd. IPO is will be disclosed closer to the issue opening. Issue size represents the total value of shares offered to the public.
As per the latest available information, the Hexagon Nutrition Ltd. IPO has been subscribed data will be available once the issue opens. Subscription levels can change significantly during the offer period.
The Grey Market Premium (GMP) for the Hexagon Nutrition Ltd. IPO is not available as of now. GMP reflects unofficial market sentiment and should not be considered a guarantee of listing performance.
The shares of Hexagon Nutrition Ltd. are expected to list on stock exchanges on Jun 12, 2026, subject to completion of the allotment process and regulatory approvals.
The net proceeds from the Hexagon Nutrition Ltd. IPO are proposed to be used for The main objectives of the issue are..., To achieve the benefits of listing the equity shares on the stock exchanges, including enhanced visibility, broader investor participation, improved liquidity for shareholders and creation of a public market for the company’s equity shares., To carry out an offer for sale that provides partial liquidity and monetization opportunity to the identified selling shareholders through transfer of their existing equity shares to public investors., To strengthen the company’s public market profile and corporate brand, which may support future growth, stakeholder confidence and wider recognition across customers, partners and institutional participants., To complete the public issue process in compliance with applicable SEBI and stock exchange requirements, while enabling discovery of a market-driven price for the offered equity shares through the book building mechanism.
Before applying for the Hexagon Nutrition Ltd. IPO, investors generally review the company’s business model, financial performance, valuation, industry outlook, and risk factors mentioned in the offer document.
